Lonza Group Ag Basic Shares Outstanding 2012-2024 | LZAGY
Lonza Group Ag annual/quarterly basic shares outstanding history and growth rate from 2012 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Lonza Group Ag basic shares outstanding for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
- Lonza Group Ag basic shares outstanding for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.
- Lonza Group Ag annual basic shares outstanding for 2024 were $0.712B, a 3.28% decline from 2023.
- Lonza Group Ag annual basic shares outstanding for 2023 were $0.736B, a 0.81% decline from 2022.
- Lonza Group Ag annual basic shares outstanding for 2022 were $0.742B, a 0.04% decline from 2021.
| Lonza Group Ag Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $712 |
| 2023 | $736 |
| 2022 | $742 |
| 2021 | $743 |
| 2020 | $744 |
| 2019 | $741 |
| 2017 | $679 |
| 2016 | $525 |
| 2015 | $523 |
| 2014 | $520 |
| 2013 | $519 |
| 2012 | $517 |
| 2011 | $529 |
| Lonza Group Ag Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $49.182B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.137B | 27.79 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $145.939B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $128.884B | 0.00 |
| Medtronic (MDT) | Ireland | $105.694B | 14.98 |
| Haleon (HLN) | United Kingdom | $51.038B | 29.05 |
| ResMed (RMD) | United States | $35.941B | 27.00 |
| GE HealthCare Technologies (GEHC) | United States | $32.753B | 15.55 |
| Agilent Technologies (A) | United States | $32.296B | 20.98 |
| Terumo (TRUMY) | Japan | $27.790B | 36.10 |
| Insulet (PODD) | United States | $22.791B | 89.46 |
| Koninklijke Philips (PHG) | Netherlands | $21.581B | 15.51 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.467B | 11.86 |
| Baxter (BAX) | United States | $15.754B | 11.76 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.622B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.194B | 21.55 |
| Lantheus Holdings (LNTH) | United States | $5.225B | 13.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.175B | 18.65 |
| Perrigo (PRGO) | Ireland | $3.730B | 9.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Haemonetics (HAE) | United States | $3.259B | 14.85 |
| Envista Holdings (NVST) | United States | $3.129B | 26.00 |
| GN Store Nord (GNNDY) | Denmark | $2.215B | 18.35 |
| QuidelOrtho (QDEL) | United States | $2.080B | 14.30 |
| LeMaitre Vascular (LMAT) | United States | $1.832B | 40.94 |
| AtriCure (ATRC) | United States | $1.687B | 0.00 |
| Neogen (NEOG) | United States | $1.348B | 17.25 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.165B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| BioLife Solutions (BLFS) | United States | $1.060B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.000B | 12.78 |
| InMode (INMD) | Israel | $0.922B | 9.29 |
| CeriBell (CBLL) | United States | $0.615B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.604B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.582B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.502B | 4.17 |
| Tilray Brands (TLRY) | Canada | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.461B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.333B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Sanara MedTech (SMTI) | United States | $0.261B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| ZimVie (ZIMV) | United States | $0.250B | 11.35 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Cerus (CERS) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| Biote (BTMD) | United States | $0.197B | 5.53 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.44 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.52 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Agape ATP (ATPC) | $0.088B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |